SUKSES (Small Cell Lung Cancer Umbrella Korea Studies): A Phase II Biomarker-Driven Umbrella Study in Relapsed or Refractory SCLC

被引:0
|
作者
Park, S. [1 ]
Hur, J. Y. [1 ]
Yoon, S. E. [1 ]
Lee, K. [1 ]
Kim, Y. [1 ]
Cho, J. H. [1 ]
Sun, J. [1 ]
Lee, S. [1 ]
Ahn, J. S. [1 ]
Ahn, M. [1 ]
Park, K. [1 ]
机构
[1] Samsung Med Ctr, Dept Med, Div Hematol Oncol, Seoul, South Korea
关键词
small cell lung cancer;
D O I
10.1016/j.jtho.2018.08.1381
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.12-05
引用
收藏
页码:S792 / S792
页数:1
相关论文
共 50 条
  • [1] Phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer (SCLC)
    Han, J.
    Lim, K. Y.
    Kim, H. Y.
    Han, J. H.
    Oh, S. H.
    Yun, T.
    Kim, H. T.
    Lee, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer (SCLC)
    Pietanza, M. C.
    Sima, C. S.
    Polley, M. R.
    Sumner, D. K.
    Travis, V.
    Heguy, A.
    Ginsberg, M. S.
    Holodny, A.
    Kris, M. G.
    Krug, L. M.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S507 - S507
  • [3] Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy
    Park, Sehhoon
    Shim, Joonho
    Mortimer, Peter G. S.
    Smith, Simon A.
    Godin, Robert E.
    Hollingsworth, Simon J.
    Kim, Hee-Jung
    Jung, Hyun Ae
    Sun, Jong-Mu
    Park, Woong-Yang
    Ahn, Jai Sang
    Ahn, Myung-Ju
    Lee, Se-Hoon
    Park, Keunchil
    CANCER, 2020, 126 (17) : 4002 - 4012
  • [4] A phase II trial of pazopanib in relapsed/refractory small cell lung cancer (SCLC).
    Gandhi, Leena
    Heist, Rebecca Suk
    Lucca, Joan Vern
    Temel, Jennifer S.
    Fidias, Panos
    Morse, Linda K.
    Johnson, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).
    Hirose, T.
    Shirai, T.
    Kusumoto, S.
    Sugiyama, T.
    Yamaoka, T.
    Okuda, K.
    Ohmori, T.
    Ohnishi, T.
    Adachi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC)
    Lovly, Christine Marie
    Li, Chung-I
    Hutchison, Anne Smith
    Carbone, David Paul
    Johnson, David H.
    Keedy, Vicki Leigh
    Pao, William
    Sandler, Alan
    Horn, Leora
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC)
    Venepalli, N. K.
    Hutchison, A. S.
    Carbone, D. P.
    Johnson, D. H.
    Keedy, V. L.
    Pao, W.
    Sandler, A.
    Horn, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer
    Park, Sehhoon
    Kim, Yu Jung
    Min, Young Joo
    Mortimer, Peter G. S.
    Kim, Hee-Jung
    Smith, Simon A.
    Dean, Emma
    Jung, Hyun Ae
    Sun, Jong-Mu
    Park, Woong-Yang
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Lee, Se-Hoon
    Park, Keunchil
    CANCER, 2024, 130 (04) : 541 - 552
  • [9] Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell Lymphoma
    Moskowitz, Alison J.
    Ghione, Paola
    Jacobsen, Eric D.
    Ruan, Jia
    Schatz, Jonathan H.
    Noor, Sarah
    Myskowski, Patricia
    Hancock, Helen
    Davey, Theresa
    Obadi, Obadi
    Onwasigwe, Carlissa
    Ganesan, Nivetha
    Pomerantz, Lauren
    Jarjies, Christine
    Kumar, Priyadarshini
    Sigler, Allison
    Geyer, Mark B.
    Noy, Ariela
    Straus, David J.
    Hollmann, Travis
    Dogan, Ahmet
    Galasso, Natasha
    Inghirami, Giorgio
    Weinstock, David M.
    Horwitz, Steven M.
    BLOOD, 2019, 134
  • [10] Biomarker driven phase II umbrella trial study of AZD1775,AZD2014,AZD2811 monotherapy in relapsed small cell lung cancer.
    Park, Sehhoon
    Shim, Joonho
    Jung, Hyun Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Park, Woong-Yang
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)